UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum ?

Frontiers in cellular and infection microbiology, 2021-02, Vol.11, p.625581-625581

2021

Volltextzugriff (PDF)

Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience

International journal of environmental research and public health, 2021-10, Vol.18 (21), p.11399

2021

Volltextzugriff (PDF)

ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection

Current medicinal chemistry, 2014-01, Vol.21 (28), p.3261

2014

Volltextzugriff (PDF)

Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019

American journal of perinatology, 2024-05, Vol.41 (S 01), p.e612

2024

Volltextzugriff (PDF)

Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection

Reviews on recent clinical trials, 2019-01, Vol.14 (3), p.173

2019

Volltextzugriff (PDF)

Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis

Antibiotics (Basel), 2022-01, Vol.11 (2), p.183

2022

Volltextzugriff (PDF)

Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis

International journal of infectious diseases, 2017-10, Vol.63 (C), p.23-29

2017

Volltextzugriff (PDF)

The role of curcumin in liver diseases

Archives of medical science, 2019-10, Vol.15 (6), p.1608-1620

2019

Volltextzugriff (PDF)

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma

Frontiers in oncology, 2021-07, Vol.11, p.705948

2021

Volltextzugriff (PDF)

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Journal of clinical medicine, 2020-12, Vol.9 (12), p.4066

2020

Volltextzugriff (PDF)

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience

Heliyon, 2023-02, Vol.9 (2), p.e13126, Article e13126

2023

Volltextzugriff (PDF)

Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients

Clinical epidemiology and global health, 2022-07, Vol.16, p.101100, Article 101100

2022

Volltextzugriff (PDF)

Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi

Reviews on recent clinical trials, 2019-01, Vol.14 (2), p.129

2019

Volltextzugriff (PDF)

Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients

EJHaem, 2022-11, Vol.3 (4), p.1172-1180

2022

Volltextzugriff (PDF)

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19

Vaccines (Basel), 2022-11, Vol.10 (12), p.2043

2022

Volltextzugriff (PDF)

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience

Frontiers in medicine, 2022-03, Vol.9, p.864865-864865

2022

Volltextzugriff (PDF)

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease

IDCases, 2019-01, Vol.17, p.e00537, Article e00537

2019

Volltextzugriff (PDF)

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era

Reviews on recent clinical trials, 2014-01, Vol.9 (1), p.1

2014

Volltextzugriff (PDF)

Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis

Expert opinion on drug safety, 2018-07, Vol.17 (7), p.709-717

2018

Volltextzugriff (PDF)

Discontinued drugs in 2012 - 2013: hepatitis C virus infection

Expert opinion on investigational drugs, 2015-02, Vol.24 (2), p.239-251

2015

Volltextzugriff (PDF)

Microbiota and hepatitis C virus in the era of direct-acting antiviral agents

Microbial pathogenesis, 2023-02, Vol.175, p.105968-105968, Article 105968

2023

Volltextzugriff (PDF)

Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?

Expert review of anti-infective therapy, 2014-07, Vol.12 (7), p.763-773

2014

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(75)
Mit Volltextzugriff
(77)

Publikationsform

Artikel
(79)
Berichte
(4)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Nasopharyngeal Microbiome Signature in COVID-19 Positive Patients: Can We Definitively Get a Role to Fusobacterium periodonticum ?

Pneumocystis jirovecii Pneumonia in Non-HIV Patients Recovering from COVID-19: A Single-Center Experience

COVID-19 in patients with thymic epithelial tumors with or without Good’s syndrome: a single-center retrospective study

ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection

Casirivimab and Imdevimab for Pregnant Women Hospitalized for Severe Coronavirus Disease 2019

Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection

Oral Vancomycin Prophylaxis for Primary and Secondary Prevention of Clostridioides difficile Infection in Patients Treated with Systemic Antibiotic Therapy: A Systematic Review, Meta-Analysis and Trial Sequential Analysis

Vitamin D deficiency is a risk factor for infections in patients affected by HCV-related liver cirrhosis

Correction to: Management of hepatitis B virus prophylaxis in patients treated with disease-modifying therapies for multiple sclerosis: a multicentric Italian retrospective study

The role of curcumin in liver diseases

Case Report: Discovery a Novel SARS-CoV-2 Variant in a Six-Months Long-Term Swab Positive Female Suffering From Non-Hodgkin Lymphoma

Prevalence of SARS-CoV-2 Antibodies in Multiple Sclerosis: The Hidden Part of the Iceberg

Casirivimab/imdevimab + remdesivir in hospitalized patients with severe Covid-19: A single centre experience

Epidemiological and clinical features of syphilis in the 21st century: A seven-year observational retrospective study of outpatients

Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of Fungi

Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients

A Simple Non-Invasive Score Based on Baseline Parameters Can Predict Outcome in Patients with COVID-19

SARS-CoV-2 in Kidney Transplant Patients: A Real-Life Experience

Invasive pulmonary aspergillosis and pulmonary tuberculosis in a patient treated with infliximab for Crohn’s disease

Efficacy and Safety of Sofosbuvir in the Treatment of Chronic Hepatitis C: The Dawn of a New Era

Risk of opportunistic infections in patients treated with alemtuzumab for multiple sclerosis

Discontinued drugs in 2012 - 2013: hepatitis C virus infection

Microbiota and hepatitis C virus in the era of direct-acting antiviral agents

Interferon-free therapies for chronic hepatitis C: toward a hepatitis C virus-free world?

Suchergebnisse filtern